Dr Eric Klein speaks to ecancer about the clinical validation of a targeted methylation-based multi-cancer early detection test.
He says this study aimed at early cancer detection which could identify tumours at a time when outcomes are superior and treatment is less morbid. It assessed the performance of targeted methylation analysis of circulating cell-free DNA (cfDNA) to detect and localise multiple cancer types across all stages at high specificity.
Dr Klein then mentions the methodology used in this study. He further discusses the key results obtained from this research. In conclusion, he talks about the future impact of this research on the treatment and diagnosis of cancer.
Sign up to ecancer for free to receive tailored email alerts for more videos like this.
ecancer.org/account/register.php
